161 related articles for article (PubMed ID: 21288650)
1. Concerns about targeting cancer stem cell for cancer therapy.
Yang G; Lu X; Fu H; Jin L; Yao L; Lu Z
Med Hypotheses; 2011 Mar; 76(3):457. PubMed ID: 21288650
[No Abstract] [Full Text] [Related]
2. Stem cells in the etiology and treatment of cancer.
Zhang M; Rosen JM
Curr Opin Genet Dev; 2006 Feb; 16(1):60-4. PubMed ID: 16377171
[TBL] [Abstract][Full Text] [Related]
3. The stem cell niche in health and malignancy.
Burness ML; Sipkins DA
Semin Cancer Biol; 2010 Apr; 20(2):107-15. PubMed ID: 20510363
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of tumor-cell heterogeneity.
Schnipper L
N Engl J Med; 1986 May; 314(22):1423-31. PubMed ID: 3517651
[No Abstract] [Full Text] [Related]
5. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
6. Is tumor growth sustained by rare cancer stem cells or dominant clones?
Adams JM; Strasser A
Cancer Res; 2008 Jun; 68(11):4018-21. PubMed ID: 18519656
[TBL] [Abstract][Full Text] [Related]
7. Roots and stems: stem cells in cancer.
Polyak K; Hahn WC
Nat Med; 2006 Mar; 12(3):296-300. PubMed ID: 16520777
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells may be mostly maintained by fluctuating hypoxia.
Sun Q; Li X; Lu X; Di B
Med Hypotheses; 2011 Apr; 76(4):471-3. PubMed ID: 21159447
[TBL] [Abstract][Full Text] [Related]
9. Tumor dormancy and oncogene addiction.
Felsher DW
APMIS; 2008; 116(7-8):629-37. PubMed ID: 18834407
[TBL] [Abstract][Full Text] [Related]
10. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
Spandidos DA
J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
[TBL] [Abstract][Full Text] [Related]
11. Successful therapy must eradicate cancer stem cells.
Dingli D; Michor F
Stem Cells; 2006 Dec; 24(12):2603-10. PubMed ID: 16931775
[TBL] [Abstract][Full Text] [Related]
12. Common themes of dedifferentiation in somatic cell reprogramming and cancer.
Daley GQ
Cold Spring Harb Symp Quant Biol; 2008; 73():171-4. PubMed ID: 19150965
[TBL] [Abstract][Full Text] [Related]
13. Special Issue "Cancer Stem Cells: Impact on Treatment".
Skvortsova I
Semin Cancer Biol; 2018 Dec; 53():iii-iv. PubMed ID: 30509407
[No Abstract] [Full Text] [Related]
14. Oncogenes, self-renewal and cancer.
Clarke MF
Pathol Biol (Paris); 2006 Mar; 54(2):109-11. PubMed ID: 16524671
[TBL] [Abstract][Full Text] [Related]
15. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.
Stindl R
Med Hypotheses; 2008; 71(1):126-40. PubMed ID: 18294777
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells: an approach to identify newer therapeutic targets.
Srivastava S; Krishna S
J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597
[TBL] [Abstract][Full Text] [Related]
17. Genetic changes in tumour microenvironments.
Campbell I; Qiu W; Haviv I
J Pathol; 2011 Mar; 223(4):450-8. PubMed ID: 21294119
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in cancer: cancer stem cells versus clonal evolution.
Shackleton M; Quintana E; Fearon ER; Morrison SJ
Cell; 2009 Sep; 138(5):822-9. PubMed ID: 19737509
[TBL] [Abstract][Full Text] [Related]
19. Origin of cancers. Clinical perspectives and implications of a stem-cell theory of cancer.
Tu SM
Cancer Treat Res; 2010; 154():v-239. PubMed ID: 20645140
[No Abstract] [Full Text] [Related]
20. Pluripotent human stem cell lines: what we can learn about cancer initiation.
Werbowetski-Ogilvie TE; Bhatia M
Trends Mol Med; 2008 Aug; 14(8):323-32. PubMed ID: 18635398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
